During intravenous infusion therapy, fluids and medications are administered through a peripherally or centrally located venous access device (VAD)
Vegan-Friendly | Non-Sticky | Non-Irritating Paraffinum Liquidum, Simmondsia Chenensis (Jojoba) Seed Oil, Hydrogenated Styrene/ Isoprene Copolymer, Polybutene, Argania Spinosa Kernel Oil, Vitis Vinifera (Grape) Seed Oil, Hydrogenated Polyisobutene, Trideceyl Trimellitate, Ascorbyl Tetraisopalmitate, Ethylene/ Propylene/ Styrene Copolymer, Tocopheryl Acetate, Aroma (Flavour), Sodium Hyaluronate, Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Butylene/ Ethylene/Styrene Copolymer, Pentaerythrityl Tetra-di-t butyl Hydroxyhydrocinnamate
Less frequent side effects (in the 25% range) include vomiting, fatigue, dizziness, nasal congestion, and cough
Biochemical determinations For human studies, serum levels of human FGF21, and plasma levels of OXM, adiponectin, GLP-1, insulin and glucagon were analyzed in a subsample of patients included in each surgical group by ELISA immunoassay according to the instructions of manufacturer
Compound Pre-blend Lyophilized 12+ months at -20 C Reconstituted (2-8 C) 28-30 days Notes Same window for both compounds in the blend
